Skip to content
City PM
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion

health

  • Record-breaking private health admissions, amid NHS crisis

    June 4, 2024

    Admissions funded by private medical insurance were at record levels, going above pre-pandemic figures for the first time.

  • Can this device help back pain caused by sitting at your desk?

    June 1, 2024

    Sitting for eight or more hours a day at a desk isn't natural for our bodies, which is why prolonged sitting can cause back pain.

  • Labour warned promise to clear NHS backlog ‘highly stretching’

    May 29, 2024

    Labour have been warned their pledge to clear the NHS backlog within five years will prove “highly stretching” and “no easy feat” by economists and policy experts.

  • Wellness Wonders: Meet the founders of probiotic supplements brand Heights

    May 26, 2024

    Mental health advocate Dan Murray-Serter and serial entrepreneur Joel Freeman, are the co-founders of the science-backed supplement brand Heights.

  • Protein Works: Sales and profit spike at challenger brand

    May 24, 2024

    The company behind challenger brand Protein Works saw its sales and profits jump during its latest financial year.

  • Non-invasive filler alternatives for healthier-looking skin

    May 23, 2024

    When wrinkles appear and gravity takes its toll on your face, you might consider invasive treatments like botox and fillers. But with skincare tech improving, it's worth holding off.

  • Infected blood scandal: Compensation payments to start this year, minister says

    May 21, 2024

    Compensation payments to the victims and families of the infected blood scandal will begin before the end of the year, the government has confirmed.

  • Based in an old Bermondsey biscuit factory, this London cancer drug firm just raised millions

    May 21, 2024

    Founded in 2012 by a PhD student, Labgenius uses technology to create more effective and safer antibodies for cancer treatment.

  • ‘New era of growth’: FTSE 100 giant Astrazeneca aims to double revenue

    May 21, 2024

    London-listed Astrazeneca reported revenue of $45.8bn in 2023 and growth of 19 per cent to $12.7bn in the first quarter of 2024.

  • ‘Day of shame’: Rishi Sunak apologises for infected blood scandal

    May 20, 2024

    Rishi Sunak has made a “wholehearted and unequivocal apology” for the infected blood scandal in what he said was a “day of shame” for  the British state.

Posts pagination

  • Previous
  • Page 1
  • …
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • …
  • Page 37
  • Next

Trending Articles

  • Top Burnham adviser calls for capital gains and inheritance tax hikes

  • A meeting with the breakfast king of Mayfair

  • Clarkson’s Farm and why businesses must stop blaming the weather

  • As it happened: Supreme Court blocks Trump sacking; Andy Burnham vows ‘greater public control’; Comcast spin-off

  • BT tops FTSE 100 after finding new home for international business with Verizon joint venture

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Editorial Policy
  • Corrections
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
About · Editorial Policy · Corrections · Contact · Privacy